A carregar...
Immunotherapy - a potential new way forward in the treatment of sepsis
A recent randomized controlled clinical trial of the immunostimulatory agent thymosin alpha-1 was conducted and showed a trend toward improved survival in patients receiving the drug (P = 0.06). Although this was a relatively small study and the exact mechanism of action of thymosin alpha-1 is not k...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4056021/ https://ncbi.nlm.nih.gov/pubmed/23425441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc12490 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|